Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.
Dynocardia has raised $675K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Dynocardia's investors include National Science Foundation, Massachusetts Medical Device Development Center (M2D2), Luminate, National Heart, Lung and Blood Institute, Mayo Clinic Platform.
Dynocardia is headquartered in Cambridge, United States.
Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.
Dynocardia is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dynocardia — Funding & Investors." VCBacked, March 14, 2025, https://www.vcbacked.co/company/dynocardia. Accessed July 19, 2026.
VCBacked. (2025). Dynocardia — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/dynocardia
{{cite web |title=Dynocardia — Funding & Investors |url=https://www.vcbacked.co/company/dynocardia |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated